Oncology Institute, Inc. - Common Stock, par value $0.0001 per share (TOI)

CUSIP: 68236X100

Q4 2025 13F Holders as of 31 Dec 2025

Security identity
Security type / class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
101,268,340
Holder snapshot
Total 13F shares
38,505,676
Share change
+3,814,679
Total reported value
$137,199,596
Put/Call ratio
1.8%
Reported price per share
$3.56
Number of holders
116
Value change
+$13,731,282
Number of buys
74
Number of sells
43

Security key

68236X100

Report period

Q4 2025

Institutions

116

Top holders

10

TOI full security history Ownership snapshot Full 13F holder table Newer quarter: Q1 2026 Previous quarter: Q3 2025 Oncology Institute, Inc. SEC filings Oncology Institute, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of TOI - Oncology Institute, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
M33 Growth I L.P.
13D/G signal
M33 Growth I L.P.
Evidence rows
15
Latest as of
01 Dec 2025
3/4/5 13D/G 13F Lead comparable stake: 5.5% 13D/G row: M33 Growth I L.P. Showing 1-6 of 15 holder rows.
Holder Evidence Ownership % Position 12M Net Δ As of
M33 Growth I L.P.
3/4/5 13D/G
Director · M33 Growth I LP
3/4/5 13D/G
5.5%
from 13D/G
$25,267,600
6,802,656 shares
mixed-class rows
 -$22,990,500 18 Nov 2025
Ravi Yang Sarin
13D/G 3/4/5
Ravi Sarin · Director
13D/G 3/4/5
4.7%
$11,959,434
4,109,771 shares
 $0 26 Mar 2025
Richard A. Barasch
3/4/5
Director
3/4/5
2.6%
$5,488,459
2,635,881 shares
mixed-class rows
 — 12 Aug 2025
Gabriel Ling
3/4/5
Director
3/4/5
0.33%
$1,537,614
333,539 shares
 — 01 Dec 2025
Anne McGeorge
3/4/5
Director
3/4/5
0.29%
$1,343,215
291,370 shares
 — 20 Nov 2025
VANGUARD GROUP INC
13F
Company
13F
4.5%
$15,862,905
4,545,245 shares
 — 30 Sep 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
116
Shares
38,505,676
Rows available
116
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
107
Q4 2025 holders
116
Holder diff
9
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 value Q4 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .